Risk of Hepatitis C Virus Exposure in Orthopedic Surgery: Is Universal Screening Needed?
Edward M. DelSole, MD, John J. Mercuri, MD, MA, Anna Stachel, MPH, CIC, Michael S. Phillips, MD, and Joseph D. Zuckerman, MD
The aging baby boomer generation will soon start using tremendous orthopedic surgical resources. This group has also been identified as a group at high risk for having undiagnosed hepatitis C virus (HCV) infection.
We conducted a study to assess the prevalence of HCV among orthopedic surgery patients at our institution—using their demographic data to determine whether they represent a unique cohort at high risk for having undiagnosed HCV. We estimated that we operated on as many as 233 patients with undiagnosed
HCV in 2011.
A cost-effective, universal preoperative HCV screening program may reduce the risk for occupational exposure in orthopedic surgery and significantly benefit public health by bringing undiagnosed patients to treatment. A robust screening program
requires several ethical considerations. By offering routine screening to patients, orthopedic surgeons have an opportunity to maintain intraoperative safety and improve the health of the public.